Sunday, September 6, 2026

2026 FIFA World Cup: Will Funding Shortages Spell Disaster for U.S. Host Cities?

U.S. cities preparing for the 2026 FIFA World Cup face funding shortages and federal support issues, threatening event readiness.

North Korea Denounces Ongoing U.S.-South Korea Joint Drill as Provocative Strike Exercise

North Korea condemns U.S.-South Korea military drills as provocative, while emphasizing party policy execution ahead of its 80th anniversary.

Lucas Paqueta to Play in 2024 Copa America Despite Betting Allegations

Midfielder Lucas Paqueta of West Ham, who...

Dae Hyeon Moon

Author's Latest

How Will Korea’s New R&D-Linked Drug Pricing Impact the Pharma Industry in 2026?

The new drug pricing reform aims to boost R&D in the pharmaceutical industry, but raises concerns for smaller firms facing cash flow issues.

Lotte Biologics Wins CDMO Leadership Award… Validates “Quality Management”

Lotte Biologics wins "Best New or Relaunched CDMO" at the 2026 CDMO Leadership Awards, showcasing rapid growth and global recognition.

GC Biopharma’s Varicella Vaccine “VARICELLAJU” Wins Approval in Guatemala

GC Biopharma's varicella vaccine VARICELLAJU gains marketing approval in Guatemala, marking its Latin American debut and ensuring safety.

JLK Secures FDA Clearance for Stroke Analysis Solution… Advancing Clinical Workflow

JLK's "JLK-NCCT" receives FDA clearance for AI-based stroke analysis, enhancing early detection and triage in emergency settings.

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Hugel Hosts Medical Aesthetics Exchange… Expanding Reach of K-Aesthetics

Hugel Inc. hosted a Medical Aesthetics International Exchange, sharing trends and techniques among Asian medical professionals.

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

Neurophet Partners with ALZ-NET: Revolutionizing Alzheimer’s Diagnosis with AI Technology

Neurophet partners with ALZ-NET to enhance Alzheimer's care through advanced AI solutions and imaging monitoring for better patient outcomes.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

Celltrion’s Groundbreaking Achievement: First Asian Bio Company to Secure APEC CBPR and Global CBPR Certifications

Celltrion becomes the first South Korean biotech firm to earn APEC CBPR and Global CBPR certifications, enhancing global data protection.

SEERS: The Transformation of a Leading AI Healthcare Company in 2026

SEERS Technology rebrands to SEERS, aiming to transform into a global digital healthcare platform with a focus on patient-centered care.

Unlocking Cancer Treatment: How TXN12923 Targets ULK1 for Enhanced Drug Sensitivity

Txinno Bioscience to present TXN12923, a novel ULK1 targeted protein degrader, at AACR, aiming to enhance cancer treatment efficacy.

Coreline Soft Provides AI Lung Cancer Screening Solution to Charité University Hospital in Germany

Coreline Soft implements AI lung cancer screening solutions at Charité University Hospital, enhancing diagnostic efficiency and consistency.

Hyundai Bioscience Launches Global Clinical Trials for Dengue Treatment in Vietnam

Hyundai BioScience launches global clinical trials for a broad-spectrum antiviral treatment targeting dengue fever in Vietnam.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.